Validation of formyl peptide receptor (FPR)2 as a target for new anti-cancer drugs [ 2012 - 2014 ]

Also known as: New receptor protein targets for novel anti-cancer drugs

Research Grant

[Cite as]

Researchers: Prof Alastair Stewart (Principal investigator) ,  A/Pr Ivan Bertoncello Dr Cameron Johnstone Prof Kelly-Anne Phillips

Brief description Treatment of breast and other cancers is making incremental improvements, but premature death from this disease and its recurrence in some women after a long period of remission are not adequately treated by current drugs. New work has identified a target called FPR2 that could be used to guide the development of novel drugs. The current project seeks to validate the new drug target, before resource intensive efforts are made to find suitable drugs.

Funding Amount $AUD 588,529.68

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]